150 related articles for article (PubMed ID: 3502537)
1. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
Musatti CC; Yasaka K; Santos LM
Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
[TBL] [Abstract][Full Text] [Related]
2. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
[TBL] [Abstract][Full Text] [Related]
3. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
4. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
[No Abstract] [Full Text] [Related]
5. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal regulation in the production of IL2 in Hodgkin's disease].
Marchiol C; Kaplan C; Chouaib S; Janvier M; Ferme C; Muller JY; Fradelizi D
C R Acad Sci III; 1985; 301(6):283-8. PubMed ID: 3928105
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
[TBL] [Abstract][Full Text] [Related]
8. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.
Ford RJ; Tsao J; Kouttab NM; Sahasrabuddhe CG; Mehta SR
Blood; 1984 Aug; 64(2):386-92. PubMed ID: 6611180
[TBL] [Abstract][Full Text] [Related]
9. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
Engleman EG; Benike C; Hoppe RT; Kaplan HS
Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
[No Abstract] [Full Text] [Related]
10. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Cancer Immunol Immunother; 1991; 34(3):205-10. PubMed ID: 1756538
[TBL] [Abstract][Full Text] [Related]
11. [Disorders of cellular immunity in Hodgkin's disease].
Burchardt K
Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
[No Abstract] [Full Text] [Related]
12. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
14. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
15. Expression and signal transduction of T-cell antigen receptor (TCR)/CD3 complexes on fresh or in vitro expanded T lymphocytes from patients with Hodgkin's and non-Hodgkin's lymphomas.
Rubin B; Martin EP; Arnaud J; Delsol G; Plesner T; Ratsimbazafy A; Llobera R; Holm B; Mariame B
Scand J Immunol; 1997 Jun; 45(6):715-25. PubMed ID: 9201313
[TBL] [Abstract][Full Text] [Related]
16. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
17. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
[TBL] [Abstract][Full Text] [Related]
18. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
[TBL] [Abstract][Full Text] [Related]
19. Abnormal phytohemagglutinin-induced T-cell proliferative responses in Hodgkin's disease.
Schulof RS; Lacher MJ; Gupta S
Blood; 1981 Mar; 57(3):607-13. PubMed ID: 6970056
[TBL] [Abstract][Full Text] [Related]
20. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
